Higher Salaries, Stock Options, And Glory: Fun And Profit In The Skin Trade

Fun And Profit In The Skin Trade From deep biology to Epidermis Inc., another tale in the merchandising of science CAMBRIDGE, MASS--Jeff Morgan and Brad Guild moved into their new office on the opening day of baseball season this April. The space was small: a single room with built-in desks lining opposite walls and barely enough room to swivel their chairs. The pair stacked boxes and unpacked a few books. And Guild took up a blue magic marker and scrawled the business’s first official

Written byBob Buderi
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Fun And Profit In The Skin Trade From deep biology to Epidermis Inc., another tale in the merchandising of science

CAMBRIDGE, MASS--Jeff Morgan and Brad Guild moved into their new office on the opening day of baseball season this April. The space was small: a single room with built-in desks lining opposite walls and barely enough room to swivel their chairs. The pair stacked boxes and unpacked a few books. And Guild took up a blue magic marker and scrawled the business’s first official insignia on the whiteboard lining one wall: "Somatix Corporate Headquarters."

The two men are more than simply the company’s first full-time employees. Both hold doctorates in biology and are former researchers at the prestigious Whitehead Institute for Biomedical Research, an affiliate of the Massachusetts Institute of Technology. Like a growing number of their colleagues, they have deserted academe for the promise of higher salaries, stock options, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies